Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00079222 · ClinicalTrials.gov registry record · NA
Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
A NA study, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
NCT00079222 is a NA study that has completed, run by Jonsson Comprehensive Cancer Center.
The verdict
NCT00079222, a NA study, has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
RATIONALE: Antifungals, such as voriconazole and itraconazole, may be effective in preventing fungal infections in patients who are undergoing allogeneic stem cell transplantation. PURPOSE: This randomized clinical trial is studying voriconazole to see how well it works compared to itraconazole in preventing fungal infections in patients who are undergoing allogeneic hematopoietic stem cell transplantation.
Interventions
- DRUG itraconazole
- DRUG voriconazole
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00079222
The ClinicalTrials.gov registry entry for NCT00079222 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which itraconazole is the first listed.
NCT00079222 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00079222 about?
NCT00079222 is a clinical study titled "Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation". RATIONALE: Antifungals, such as voriconazole and itraconazole, may be effective in preventing fungal infections in patients who are undergoing allogeneic stem cell transplantation. PURPOSE: This randomized clinical trial is studying voriconazole to see how well it works compared to itraconazole in ...
What is the current status of trial NCT00079222?
This trial is currently completed. It is a NA study. The study started on 2003-11.
What interventions are being tested in trial NCT00079222?
The interventions under investigation include: itraconazole (DRUG), voriconazole (DRUG).
Who is sponsoring clinical trial NCT00079222?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.